Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001447028-25-000040)

Filing Details

Accession Number:: 0001447028-25-000040
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-02-05 16:02:55
Reporting Period:: 2025-02-04

Filing Date:: 2025-02-05
Accepted Time:: 2025-02-05 16:02:55
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1447028	Arbutus Biopharma Corp	ABUS	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1237401	C David Hastings	C/O Arbutus Biopharma Corporation 701 Veterans Circle Warminster PA 18974	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2025-02-04	22,183	$3.28	159,724	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents the non-discretionary sale of common shares pursuant to the Reporting Person's 10b5-1 Plan, adopted on March 6, 2023, to satisfy the Reporting Person's tax obligations with respect to the vesting of previous grants of restricted stock units.